Precision Medicine News and Updates | Precision Medicine Online
WEBThe plan, announced in January, would reclassify many Class III in vitro diagnostic devices as Class II, impacting companion diagnostic and infectious disease tests. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBSep 16, 2024. AI-Driven Genomic Test Shows Promise in De-Escalating Neoadjuvant TNBC Therapy. Sep 15, 2024. TORL BioTherapeutics' CLDN6-Targeting Antibody-Drug Conjugate Demonstrates Encouraging Early Results. Sep 15, 2024. Bristol Myers Squibb's Krazati Bests Chemo in KRAS-Mutant NSCLC With Brain Metastases. Sep 15, 2024.
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Precision Medicine Diagnostics
WEBBioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs. Sep 13, 2024. AbbVie's Telisotuzumab Vedotin Effective in NSCLC Patients With High, Intermediate c-MET Expression. Sep 12, 2024. Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes.
Breaking News - Precision Medicine Online
WEBSep 13, 2024 · Population Testing for BRCA1/2 Appears Cost-Effective in Younger Canadian Women. Using simulated data for 1 million women, researchers found that population-based BRCA1/2 testing would be cost-effective, particularly in 30-year-old women. Sep 13, 2024.
Price of Precision: Patients, Oncologists Highlight Costs of Fighting ...
WEBJun 1, 2023 · NEW YORK — The side effects of cancer treatments are notoriously arduous, but the market entry of high-priced biomarker-informed drugs and immunotherapies has introduced another type of toxicity to the cancer lexicon — financial toxicity.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Cardiovascular Disease Research News - Precision Medicine Online
WEBJul 3, 2024 · FDA Lifts Hold on 4D Molecular Therapeutics' Fabry Disease Cardiomyopathy Gene Therapy Trial. Now that the clinical hold has lifted, 4DMT said it expects to resume enrollment in the Phase I/II trial evaluating 4D-310 in the second half of 2024. A case series published last month shows the KRAS-inhibiting cancer drug can also improve symptoms in ...
coronary artery disease - Precision Medicine Online
WEBThe UK-based company is developing a bioinformatics platform to identify in vivo biomarkers of coronary artery disease to enable personalized treatments. Combination of Polygenic, Social, Clinical Factors Improve Prediction of Heart Disease Risk A model of these three measures improved heart ...
Breaking News - Precision Medicine Online
WEBUnder the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.